Kratisto Investing: Idea List

Pages

Home
Portfolio
Performance
Bio
Idea List
Contact

Idea List

Coming back soon...

Email This BlogThis!Share to Twitter Share to Facebook Share to Pinterest

Home

Subscribe to: Posts (Atom)

Search This Blog

About Me

Stephen Simpson, CFA: I started this blog as a way of archiving my writing for sites like Investopedia, as well as posting some thoughts on the markets, stocks, or whatever else strikes my fancy. Feel free to email me. You can reach me at tuonela (dot) fool (at) gmail (dot) com

View my complete profile

Get My Articles Delivered By Email

Followers

Subscribe To

Posts

Atom

Posts

All Comments

Atom

All Comments

Disclaimer

This blog represents the opinions and views of its author.

Information is taken from sources believed to be reliable but no warranty or guarantee is made with respect to accuracy.

Investing involves risk and requires proper due diligence. In no way should a reader should presume this blog represents personalized financial advice or is a substitute for proper due diligence. The author expects you to be enough of a grown-up to realize this.

Blog Archive

▼ 2017 (178)
- ▼ June (9)
- ► May (38)
- ► April (34)
- ► March (31)
- ► February (34)
- ► January (32)

► 2016 (395)
- ► December (36)
- ► November (29)
- ► October (44)
- ► September (31)
- ► August (42)
- ► July (25)
- ► June (2)
- ► May (18)
- ► April (29)
- ► March (42)
- ► February (57)
- ► January (40)

► 2015 (424)
- ► December (33)
- ► November (8)
- ► October (9)
- ► September (12)
- ► August (12)
- ► July (66)
- ► June (70)
- ► May (70)
- ► April (48)
- ► March (14)
- ► February (24)
- ► January (58)

► 2014 (835)
- ► December (13)
- ► November (8)
- ► October (9)
- ► September (61)
- ► August (74)
- ► July (100)
- ► June (80)
- ► May (99)
- ► April (105)
- ► March (103)
- ► February (82)
- ► January (101)

► 2013 (1073)
- ► December (101)
- ► November (33)
- ► October (55)
- ► September (79)
- ► August (121)
- ► July (130)
- ► June (120)
- ► May (92)
- ► April (79)
- ► March (60)
- ► February (89)
- ► January (114)

► 2012 (1257)
- ► December (97)
- ► November (70)
- ► October (89)
- ► September (92)
- ► August (90)
- ► July (128)
- ► June (89)
- ► May (105)
- ► April (134)
- ► March (99)
- ► February (125)
- ► January (139)

► 2011 (919)
- ► December (87)
- ► November (72)
- ► October (86)
- ► September (66)
- ► August (81)
- ► July (87)
- ► June (63)
- ► May (72)
- ► April (85)
- ► March (77)
- ► February (66)
- ► January (77)

► 2010 (600)
- ► December (84)
- ► November (75)
- ► October (75)
- ► September (63)
- ► August (74)
- ► July (94)
- ► June (60)
- ► May (48)
- ► April (27)

► 2009 (3)
- ► February (1)
- ► January (2)

► 2008 (69)
- ► December (17)
- ► November (17)
- ► October (32)
- ► September (2)
- ► August (1)

Popular Posts

Seeking Alpha : Should Investors Add Adtran After Fourth Quarter Earnings?

Such is the state of business for companies that supply equipment to carriers like Verizon ( VZ ) like AT&T ( T ) that not missing nu...
Seeking Alpha: The Tricky Case Of Helen Of Troy

It's been a while since I've written on Helen Of Troy (NASDAQ: HELE ). While I've long liked the company's growth-by-acqui...
Seeking Alpha: Lundbeck Continues To Rebuild Its Reputation

It may be good advice to not look a gift horse in the mouth, but it's also a pretty good idea to not get overly excited about unreliabl...
Seeking Alpha: Arch Capital's Superior Model Continuing To Pay Off

Arch Capital (NASDAQ: ACGL ) has been one of my favorite insurance companies for a long time , and I greatly admire the company's focu...
Seeking Alpha: GOME Still Looking To Adapt To China's Evolving Retail Market

It's been a tough year for GOME Electrical Appliances ( OTCPK:GMELY ) (0493.HK). Although I thought the shares were fully valued when I...
Seeking Alpha: COPEL Will Take Its Licks In 2016, But The Future Is More Promising

There are valid reasons for Brazilian utilities to still be trading well below past valuation levels. Electricity demand continues to fall ...
Will Amylin Succeed Where Other Obesity Drugs Fail?

With Vivus (Nasdaq: VVUS) and Arena (Nasdaq: ARNA) going down in flames during FDA panel meetings for their obesity drugs, and Orexigen (...
Seeking Alpha: The Excruciating Wait At GenMark Drags On

When I last wrote about GenMark Diagnostics (NASDAQ: GNMK ) in October of 2015, I said things like "barring another significant dela...
With Headwaters, Bad Weather Means Opportunity

I believe investors do well to cast a skeptical gaze at companies that chronically blame factors outside their control for ongoing underp...
Heineken Well-Placed And Well-Run, But Also Well-Valued

Inspired by the impending takeover of SABMiller ( OTCPK:SBMRY ) by Anheuser Busch InBev (NYSE: BUD ) (or "AB InBev"), I decide...